[The challenge of administering anti-tuberculosis treatment in infants and pre-school children. pTBred Magistral Project].

[1]  I. Melki,et al.  Ethambutol-related Impaired Visual Function in Childrens Less than 5 Years of Age Treated for a Mycobacterial Infection: Diagnosis and Evolution , 2015, The Pediatric infectious disease journal.

[2]  M. C. Ortega,et al.  Conocimiento sobre el uso de fármacos off-label en Pediatría: Resultados de una encuesta pediátrica nacional 2012-2013 (estudio OL-PED) , 2014 .

[3]  Benjamin M. Smith,et al.  Fixed-dose combination antituberculosis therapy: a systematic review and meta-analysis , 2013, European Respiratory Journal.

[4]  R. de Groot,et al.  Pharmacokinetics of anti‐tuberculosis drugs in Venezuelan children younger than 16 years of age: supportive evidence for the implementation of revised WHO dosing recommendations , 2012, Tropical medicine & international health : TM & IH.

[5]  S. Roll,et al.  Pharmacokinetics of Isoniazid, Rifampin, and Pyrazinamide in Children Younger than Two Years of Age with Tuberculosis: Evidence for Implementation of Revised World Health Organization Recommendations , 2011, Antimicrobial Agents and Chemotherapy.

[6]  A. Montaner,et al.  Fe de errores de «Diagnóstico de la tuberculosis en la edad pediátrica. An Pediatr (Barc). 2010;72(4):283.e1–e14» , 2011 .

[7]  L. Rigouts,et al.  Efficacy and safety of a 4-drug fixed-dose combination regimen compared with separate drugs for treatment of pulmonary tuberculosis: the Study C randomized controlled trial. , 2011, JAMA.

[8]  A. Montaner,et al.  [Diagnosis of tuberculosis in pediatrics. Consensus document of the Spanish Society of Pediatric Infectology (SEIP) and the Spanish Society of Pediatric Pneumology (SENP)]. , 2010, Anales de pediatria.

[9]  D. Moreno-Pérez,et al.  Documento de consenso de la Sociedad Española de Infectología Pediátrica sobre la tuberculosis resistente a fármacos , 2009 .

[10]  D. M. Pérez.  Documento de consenso sobre el tratamiento de la tuberculosis extrapulmonar y formas complicadas de tuberculosis pulmonar , 2008 .

[11]  J. M. C. Rauet,et al.  Documento de consenso sobre el tratamiento de la tuberculosis pulmonar en niños , 2007 .

[12]  D. Maher,et al.  Ethambutol dosage for the treatment of children: literature review and recommendations. , 2006, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[13]  J. A. Fernández,et al.  Documento de consenso sobre el tratamiento de la exposición a tuberculosis y de la infección tuberculosa latente en niños , 2006 .

[14]  R. Panchagnula,et al.  Comparative bioavailability of rifampicin, isoniazid and pyrazinamide from a four drug fixed dose combination with separate formulations at the same dose levels. , 2004, International journal of pharmaceutics.

[15]  M. M. Peña.  Interpretación de la prueba de tuberculina en niños , 2003 .

[16]  F. Ehring.  [Dissolved tuberculostatics. A safe intake method during hospitalization]. , 1971, Praxis der Pneumologie.